ERG and cancer: Data from next generation sequencing studies demonstrate that such deletions are more prevalent than any mutations of specific coding genes and many of these deletions have been linked to either ERG-positive (i.e. PTEN and 3p13)38, 39 or ERG-negative cancers (i.e. 6q15 and 5q23)40, 41.